Insider Trading Alert - SNV, NOR And PRXL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 18, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.00 to $575,784,180.28.

Highlighted Stocks Traded by Insiders:

Synovus Financial (SNV) - FREE Research Report

Perry Curtis J, who is EVP& Chief Corp Banking Office at Synovus Financial, sold 7,600 shares at $28.45 on May 18, 2015. Following this transaction, the EVP& Chief Corp Banking Office owned 58,585 shares meaning that the stake was reduced by 11.48% with the 7,600-share transaction.

The shares most recently traded at $29.29, up $0.84, or 2.87% since the insider transaction. Historical insider transactions for Synovus Financial go as follows:

  • 4-Week # shares bought: 5,654
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 5,654
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 5,654
  • 24-Week # shares sold: 6,400

The average volume for Synovus Financial has been 985,600 shares per day over the past 30 days. Synovus Financial has a market cap of $3.8 billion and is part of the financial sector and banking industry. Shares are up 7.09% year-to-date as of the close of trading on Monday.

Synovus Financial Corporation operates as the bank holding company for Synovus Bank that provides various financial products and services. It offers integrated financial services, including commercial and retail banking, financial management, insurance, and mortgage services. The stock currently has a dividend yield of 1.41%. The company has a P/E ratio of 20.6. Currently, there are 5 analysts who rate Synovus Financial a buy, 2 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SNV - FREE

TheStreet Quant Ratings rates Synovus Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Synovus Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Noranda Aluminum (NOR) - FREE Research Report

Sagor Elliot G., who is Director at Noranda Aluminum, bought 10,000 shares at $2.34 on May 18, 2015. Following this transaction, the Director owned 10,000 shares meaning that the stake was boosted by 100% with the 10,000-share transaction.

The shares most recently traded at $2.17, down $0.17, or 7.83% since the insider transaction. Historical insider transactions for Noranda Aluminum go as follows:

  • 4-Week # shares bought: 85,000
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 85,086
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 85,147
  • 24-Week # shares sold: 20,000

The average volume for Noranda Aluminum has been 869,000 shares per day over the past 30 days. Noranda Aluminum has a market cap of $160.6 million and is part of the basic materials sector and metals & mining industry. Shares are down 34.38% year-to-date as of the close of trading on Monday.

Noranda Aluminum Holding Corporation produces and sells primary aluminum and rolled aluminum coils in the United States. The company's Bauxite segment mines, produces, and sells bauxite used for alumina production. The stock currently has a dividend yield of 1.72%. Currently, there is 1 analyst who rates Noranda Aluminum a buy, 2 analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NOR - FREE

TheStreet Quant Ratings rates Noranda Aluminum as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Noranda Aluminum Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Parexel International (PRXL) - FREE Research Report

Love Richard L, who is Director at Parexel International, sold 5,000 shares at $65.00 on May 18, 2015. Following this transaction, the Director owned 85,680 shares meaning that the stake was reduced by 5.51% with the 5,000-share transaction.

The shares most recently traded at $67.29, up $2.29, or 3.4% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 455
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 455
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 455
  • 24-Week # shares sold: 17,623

The average volume for Parexel International has been 446,600 shares per day over the past 30 days. Parexel International has a market cap of $3.7 billion and is part of the health care sector and health services industry. Shares are up 21.9% year-to-date as of the close of trading on Monday.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has a P/E ratio of 24.3. Currently, there are 5 analysts who rate Parexel International a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings rates Parexel International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Parexel International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook's Investors Have a Big Day Ahead

Facebook's Investors Have a Big Day Ahead

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Comcast Details $30 Billion Bid for Britain's Sky in Takeover Battle With Fox

Comcast Details $30 Billion Bid for Britain's Sky in Takeover Battle With Fox